This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Shengping Medical Equipment Co., Ltd., Vastpro (Zhejiang) Pharmaceutical Co., Ltd., Zhejiang Boxiao Biopharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2026
Title: Liang Lai: Inventor of a Tetrodotoxin Synthesis Method.
Introduction
Liang Lai is an inventor associated with Shanghai, China. His patent describes a biological and chemical method for synthesizing tetrodotoxin, a compound traditionally obtained by extraction from pufferfish.
Latest Patents
Lai’s listed patent is “Method for Large-Scale Synthesis of Tetrodotoxin.” It begins with benzyl acetate, an inexpensive and readily available raw material, and uses biological fermentation to produce an optically pure intermediate. A series of chemical conversions then yields tetrodotoxin with a reported purity of at least 95%, without purifying the product. The method is presented as having potential for large-scale production and as an alternative to extraction from pufferfish. Lai is associated with 1 patent.
Career Highlights
Lai has been associated with Shanghai Shengping Medical Equipment Co., Ltd. and Vastpro (Zhejiang) Pharmaceutical Co., Ltd. His listed invention focuses on a synthesis route intended to support the production of tetrodotoxin.
Collaborations
Lai’s listed coworkers include Guangyin Wang and Xiaoming Li.
Conclusion
Liang Lai’s patent presents a biological and chemical approach to producing tetrodotoxin, with the stated potential to offer a scalable alternative to pufferfish extraction.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile